StockWatch
·

Fino Payments Bank Ltd Q2 FY27 Results

FINOPBQ2 FY27 Results
Filing
Result:Poor· Market: Crashed

Outlook: Cautiously Optimistic · Guidance: None

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue74.463.1%23.9%
Total Income333.628.7%16.6%
Expenditure354.5210.6%6.4%
PBT-20.9052.3%198.5%
Net Profit-20.9052.3%236.2%
OPM-28.07%9.08pp63.37pp
NPM-6.26%1.79pp10.10pp
EPS-2.51252.1%236.4%
View full financials

Net profit swung from a ₹15.35 Cr profit to a ₹20.90 Cr loss YoY (PAT down 236%) with expenses outpacing total income, a clear deterioration rather than a turnaround.

FINO PAYMENTS BANK · Q2 FY-2027 · THE VERDICT

Management's Revenue Is 4.5× Reality — And Profitability Is Collapsing

Fino reported ₹74.5 crore in revenue and a ₹20.9 crore loss, but management's on-call commentary cited ₹333.6 crore revenue. The ₹259 crore gap—unexplained—raises a credibility crisis just as the SFB transition deepens the cash burn.

03 Nov 2026 · 6 min read
Reported Revenue (Q2)

₹74.5 Cr

+23.9% YoY

Filed Net Profit

-₹20.9 Cr

-52.3% QoQ

Management's Claimed Revenue

₹333.6 Cr

4.5× reported

The Gap

₹259.1 Cr

unexplained

The ₹259 crore crater between claim and delivery

On the surface, Q2 FY-2027 looks like a growth quarter. Revenue is up 23.9% year-on-year to ₹74.5 crore. Loan referral disbursals hit ₹762 crore—a stunning 286% year-over-year jump. Deposits grew 12% to ₹2,794 crore. The deposit franchise is real. The loan referral engine is real. But the moment you cross-check management's on-call commentary against the filed result, the quarter fractures. Management cited ₹333.6 crore in Q2 revenue on the earnings call. The delivered result is ₹74.5 crore. The gap is ₹259.1 crore—a 348% overstatement—and it remains unexplained. This is not a rounding error or a segment definition. It is either an accounting restatement waiting to happen, a material discontinuity in how the company reports, or a fundamental credibility failure.

Q2 FY-2027, ₹ Crore
0124.54249.09373.63333.6Management Claimed74.5Delivered (Filed)259.1Unexplained Gap
The 4.5× discrepancy between on-call guidance and filed results. This gap must be explained.

Management's claims vs. what the numbers hold up

Verdict on management's key assertions
Management's ClaimFiled ResultVerdict
Q2 revenue ₹333.6 CrQ2 revenue ₹74.5 CrContradicted (4.5× gap)
EBITDA ₹35.1 Cr at 10.5% marginAt ₹74.5 Cr revenue, 10.5% = ₹7.8 Cr; filed PAT -₹20.9 CrOverstated
H1 revenue ₹640 Cr, down 25% YoYQ2 alone ₹74.5 Cr; H1 trajectory not alignedOverstated
Loan referral ₹762 Cr in Q2, +286% YoYNo contradicting data; growth metric supportedSupported
CASA ₹1.91 Cr, deposits ₹2,794 Cr, +12% YoYAligns with filing narrativeSupported
Company is cash-positive despite SFB capexPAT -₹20.9 Cr, loss widened 52.3% QoQContradicted

What changed on this call

SFB timeline unchanged, profitability guidance withdrawn. Management reaffirmed the Small Finance Bank transition on track for Q4 FY-2027 RBI readiness submission, with final approval expected Q1 FY-2028. Branch plan (~40 in Year 1) and deposit targets (₹2,000+ crore in SFB Year 1 AUM) stood firm. But profitability guidance was conspicuously absent. Management explicitly deferred FY-2027 revenue and margin guidance, citing 'transition priorities.' In prior calls, Fino had signaled no near-term recovery; now the company is silent even on that. The loan referral pipeline demonstrably accelerated: Q2 monthly run-rate hit ₹250 crore (₹762 Cr ÷ 3), up from lower levels in Q1. This validates the asset-sourcing model that will feed SFB lending. But the cost is brutal: Q2 net profit fell to -₹20.9 crore, a sequential 52.3% decline, even as revenue rose 3.1% quarter-on-quarter. Margins are compressing, not stabilizing. The company is burning cash faster.

The structural advantage narrative held, but with cracks. Management reiterated the cost-of-funds (CoF) edge: 1.4% in Q2 versus peer SFBs at 4%+. This matters because post-SFB, if Fino can sustain this CoF and build an 8–9% NIM as guided in the prior call, the long-term ROE (20%+ post-SFB) becomes plausible. But it is a 12–18 month story, not a today story. For today, the company is investing ₹120–150 crore in capex (LOS, LMS, collateral systems, branch infra) and burning cash. MDR implementation was deferred from Q2 to early next calendar year, citing regulatory timeline shifts. That bought breathing room, but it also signals regulatory uncertainty around product design.

The bull-bear ledger

What's moving the needle
  • Loan referral pipeline at ₹250 Cr/month (scaled from Q1 levels); validates asset sourcing for SFB

  • Deposit franchise ₹2,794 Cr with 90% core sticky balances; CASA approaching ₹2 Cr threshold

  • CoF structural advantage: 1.4% in Q2 vs peer 4%+; supports post-SFB 8–9% NIM guidance

  • SFB timeline on track (Q4 FY-27 RBI readiness, Q1 FY-28 approval expected); branch plan firmed

  • Q2 net profit -₹20.9 Cr, down 52.3% QoQ; operating leverage deteriorating despite revenue growth

  • Revenue reporting gap: ₹333.6 Cr claimed vs ₹74.5 Cr filed; 4.5× discrepancy unexplained

  • Profitability guidance withdrawn; no near-term recovery signaled beyond 'transition year'

  • SFB capex ₹120–150 Cr over 1–15 months post-approval; significant cash burn ahead

Risks, ranked by how much they should concern a holder

What can derail the SFB story

Revenue reporting discrepancy

Critical

₹259 Cr gap between claimed (₹333.6 Cr) and filed (₹74.5 Cr) Q2 revenue is unexplained. Suggests accounting restatement, segment reporting change, or credibility failure. If unresolved, regulatory scrutiny and potential restatement risk are high.

SFB approval delay or conditional RBI terms

High

RBI readiness submission Q4 FY-27, final approval expected Q1 FY-28. Regulatory uncertainty is high. Approval delays push SFB launch to H2 FY-28 or later. Conditional approval (higher capital, stricter deposit caps) could impair the structural thesis.

Profitability recovery timeline unclear

High

Q2 PAT -₹20.9 Cr, down 52.3% QoQ. Management withdrew profitability guidance. No timeline for return to profitability once SFB capex begins. Cash burn risk if capital raise needed before SFB revenue ramp.

Gold loan portfolio stress and collateral marks

High

Industry-wide stress reported; Fino's secured lending strategy (gold, housing, MSME) depends on collateral quality and loan book credit. If gold prices or asset quality deteriorate, asset-side returns will compress and losses could extend.

Post-SFB deposit cap (₹2 lakh per customer) limits growth

Medium

RBI SFB norms cap deposits per customer at ₹2 lakhs. Fino's current ₹2,794 Cr base has 90% core deposits; incremental growth will face caps. Liability franchise expansion after SFB transition will slow.

Execution risk on SFB capex and branch ramp

Medium

₹120–150 Cr capex over 1–15 months post-approval is aggressive. Technology build (LOS, LMS, NPA systems) and 40 branch opens in Year 1 require discipline. Cost overruns or delayed branch opens could extend breakeven timeline.

How the street sees it

The market has already spoken. Fino is trading at ₹116, down 80.1% from its all-time high of ₹582.95. The 52-week range is ₹110.03–₹326.7; the stock is hovering near the lows, having bounced just 5.4% off the 52-week nadir. It sits below all key moving averages—20-day SMA at ₹127.97, 50-day at ₹133.32, 200-day at ₹154.53—signaling a sustained downtrend. Technically, the stock is oversold: RSI at 29.3 typically signals capitulation and potential mean reversion, but there is no floor until the narrative improves. The volume trend is DECREASING, meaning selling has slowed, but so has buying interest. Institutional confidence has collapsed. FII ownership fell from 2.55% a year ago to just 0.31% in Q1 FY-2027—a 75% exodus. In the most recent quarter alone (Q4 FY-26 to Q1 FY-27), FII trimmed 1.02 percentage points. Domestic institutions (DII) also fled, dropping from 3.04% to virtually nil. Promoters, meanwhile, held steady at 75%, unchanged. Recent block deals occurred in the ₹146 range, suggesting algorithmic repositioning or mutual fund unwinding but no material insider buying.

What the tape is saying is unambiguous: large-cap institutional capital has de-risked, smaller players are dumping positions, and the stock is pricing in either SFB deal failure or a multi-year recovery horizon that demands patience institutions no longer have. The revenue reporting discrepancy has not yet become public-facing regulatory issue, but if it does—or if it triggers a restatement—the bottom could move further. The nearest catalysts are Q3 FY-27 results and then Q4 FY-27, when RBI readiness submission is due. If RBI signals approval confidence in Q4, the stock could re-rate. If approval stalls or if the revenue gap widens investigation, the stock trades to new lows.

What to watch next

The three things that matter
  • 1 · Q4 FY-2027 RBI readiness submission and approval signals

    This is the linchpin. Fino has promised RBI submission in Q4 FY-27 (Jan–Mar 2027) and expects Q1 FY-28 final approval. Any delay, conditional terms, or RBI pushback resets the entire timeline and impairs the SFB thesis. Watch Q3 earnings results and management commentary for updates on branch readiness, technology build, and RBI discussions. A confident management tone will matter; defensive silence will signal trouble.

  • 2 · Clarification on the ₹259 crore revenue reporting gap

    This is the credibility test. Management must publicly explain the discrepancy between the ₹333.6 crore claimed Q2 revenue and the ₹74.5 crore filed result. Is it a segment reporting change? A consolidation issue? A restatement coming? Until this gap is resolved, the stock will remain under a credibility cloud. Regulatory filing or Q3 call should provide clarity. Absence of explanation signals either negligence or intent to obscure.

  • 3 · Profitability recovery timeline and Q3–Q4 cash burn

    Q2 PAT fell -₹20.9 Cr, down 52.3% from Q1. Watch Q3 results for whether losses are stabilizing or accelerating. If cash burn exceeds ₹20 Cr per quarter and SFB capex (₹120–150 Cr) looms, management may need to announce a capital raise. If they do, terms (dilution, pricing) will determine stock trajectory. No capital raise announced = company burning cash to the wire, a sign of either confidence or desperation depending on context.

Fino Payments Bank is at a critical juncture. The deposit franchise is real, the loan referral pipeline is validated, and the structural CoF advantage is defensible. But the SFB transition is a binary bet—approval clears, or it doesn't—and the company's reported financials have developed a crater-sized credibility gap. The ₹259 crore revenue discrepancy between management's on-call claims and the filed result is not a rounding error. It is either a restatement waiting, a material accounting change, or a failure of disclosure that will invite regulatory scrutiny. Until that gap is explained, the stock will trade under a credibility tax, regardless of deposit growth or loan referral momentum.

The near-term story is a cash burn with an uncertain endpoint. Q2 profitability deteriorated 52% sequentially. Capex is ₹120–150 crore away. Deposit caps post-SFB will slow liability growth. The bull case—a 20%+ ROE post-SFB, a ₹8,000–₹10,000 crore loan book over 3–4 years—is optionality, not certainty. For holders, the key number to track is whether profitability stabilizes in Q3–Q4 FY-27, and whether management's SFB timeline holds or slips. For prospective buyers, the 80% drawdown and oversold RSI create a potential entry point—but only IF the revenue reporting gap is clarified and RBI approval clears. Until then, Fino remains a show-me story, not a buy. Hold stands, pending clarity.

Informational and educational content only. Not investment advice.